References

REFERENCES

Abegunde, D., and A. Stanciole. 2006. “An Estimation of the Economic Impact of Chronic

Noncommunicable Diseases in Selected Countries.” Department of Chronic Diseases and

Promotion Working Paper, World Health Organization, Geneva. https://www.who.int/chp /working_paper_growth%20model29may.pdf. Alzaabi, A., M. Alseiari, and B. Mahboub. 2014. “Economic Burden of Asthma in Abu Dhabi: A

Retrospective Study.” ClinicoEconomics and Outcomes Research 6: 445–50. https://pubmed .ncbi.nlm.nih.gov/25378938/. Arnold, M., N. Pandeya, G. Byrnes, A. G. Renehan, G. A. Stevens, M. Ezzati, J. Ferlay, J. J. Miranda,

I. Romieu, R. Dikshit, D. Forman, and I. Soergomataram. 2015. “Global Burden of Cancer

Attributable to High Body-Mass Index in 2012: A Population-Based Study.” Lancet Oncology 16 (1): 36–46. doi:10.1016/S1470-2045(14)71123-4. Asia Pacific Cohort Studies Collaboration. 2007. “The Burden of Overweight and Obesity in the

Asia–Pacific Region.” Obesity Review 8 (3): 191–96. doi:10.1111/j.1467-789X.2006.00292.x. Birmingham, C. L., J. L. Muller, A. Palepu, J. J. Spinelli, and A. H. Anis. 1999. “The Cost of Obesity in Canada.” Canadian Medical Association Journal 160 (4): 483–88. Bloom, D. E., E. T. Cafiero, E. Jané-Llopis, S. Abrahams-Gessel, L. R. Bloom, S. Fathima,

A. B. Feigl, T. Gaziano, M. Mowafi, A. Pandya, K. Prettner, L. Rosenberg, B. Seligman,

A. Z. Stein, and C. Weinstein. 2011. The Global Economic Burden of Non-Communicable

Diseases. Geneva: World Economic Forum.

Bloom, D. E., E. T. Cafiero, M. E. McGovern, K. Prettner, A. Staniciole, J. Weiss, S. Bakkila, and

L. Rosenberg. 2013. “The Economic Impact of Non-Communicable Disease in China and

India: Estimates, Projections, and Comparisons.” IZA Discussion Paper 7563, Institute of

Labor Economics, Bonn. http://ftp.iza.org/dp7563.pdf. Bloom, D. E., A. Chen, and M. E. McGovern. 2018. “The Economic Burden of Non-Communicable

Diseases and Mental Health Conditions: Results for Costa Rica, Jamaica, and Peru.” Pan

American Journal of Public Health 42 (e18). https://scholar.harvard.edu/mcgovern /publications/economic-burden-non-communicable-diseases-and-mental-health -conditions-results.

Butland, B., S. Jebb, P. Kopelman, K. McPherson, S. Thomas, J. Mardell, and v. Parry. 2007.

Foresight—Tackling Obesities: Future Choices, Project Report. London: UK Department of

Innovation, Universities and Skills. https://assets.publishing.service.gov.uk/government /uploads/system/uploads/attachment_data/file/287937/07-1184x-tackling-obesities -future-choices-report.pdf. Cawley, J., J. A. Rizzo, and K. Haas. 2007. “Occupation-Specific Absenteeism Costs Associated with Obesity and Morbid Obesity.” Journal of Occupational and Environmental Medicine 49 (12): 1317–24. doi:10.1097/JOM.0b013e31815b56a0. Cecchini, M., and S. vuik. 2019. “The Heavy Burden of Obesity,” in The Heavy Burden of Obesity:

The Economics of Prevention. Paris: OECD. https://doi.org/10.1787/3c6ec454-en. Dal Grande, E., T. Gill, L. Wyatt, C. R. Chittleborough, P. J. Phillips, and A. W. Taylor. 2009.

“Population Attributable Risk (PAR) of Overweight and Obesity on Chronic Diseases: South

Australian Representative, Cross-Sectional Data, 2004–2006.” Obesity Research and Clinical

Practice 3 (3): 159–68. doi:10.1016/j.orcp.2009.03.004. Dalal, A. A., L. Christensen, F. Liu, and A. A. Reidel. 2010. “Direct Costs of Chronic Obstructive

Pulmonary Disease among Managed Care Patients.” International Journal of Chronic

Obstructive Pulmonary Disease 5: 341–40. https://www.ncbi.nlm.nih.gov/pmc/articles /PMC2962300/. Devaux, M., A. Lerouge, B. ventelou, Y. Goryakin, A. Feigl, S. vuik, and M. Cecchini. 2019.

“Assessing the Potential Outcomes of Achieving the World Health Organization Global

Non-Communicable Diseases Targets for Risk Factors by 2025: Is There Also an Economic

Dividend?” Public Health 169: 173–79. doi:10.1016/j.puhe.2019.02.009. Ding, D., K. D. Lawson, T. L. Kolbe-Alexander, E. A. Finkelstein, P. T. Katzmarzyk, W. van Mechelen,

M. Pratt, and the Lancet Physical Activity Series 2 Executive Committee. 2016. “The Economic

Burden Of Physical Inactivity: A Global Analysis of Major Non-Communicable Diseases.”

Lancet 388 (10051): 1311–24. doi:10.1016/S0140-6736(16)30383-X.

Finkelstein, E. A., M. daCosta DiBonaventura, S. M. Burgess, and B. C. Hale. 2010. “The Costs of

Obesity in the Workplace.” Journal of Occupational and Environmental Medicine 52 (10): 971–76. doi:10.1097/JOM.0b013e3181f274d2. Finkelstein, E., I. C. Fiebelkorn, and G. Wang. 2005. “The Costs of Obesity among Full-Time

Employees.” American Journal of Health Promotion 20: 45–51. doi:10.4278 /0890-1171-20.1.45. Flegal, K. M., O. A. Panagiotou, and B. I. Graubard. 2015. “Estimating Population Attributable

Fractions to Quantify the Health Burden of Obesity.” Annals of Epidemiology 25: 201–07. doi:10.1016/j.annepidem.2014.11.010. GBD 2015 Obesity Collaborators. 2017. “Health Effects of Overweight and Obesity in 195

Countries over 25 Years.” New England Journal of Medicine 377 (1): 13–27. doi:10.1056/

NEJMoa1614362.

Goryakin, Y., A. Aldea, A. Lerouge, v. Romano Spica, N. Nante, S. vuik, M. Devaux, and

M. Cecchini. 2019. “Promoting Sport and Physical Activity in Italy: A Cost-Effectiveness

Analysis of Seven Innovative Public Health Policies.” Annali di igiene: medicina preventiva e di comunita 31 (6): 614–25. doi:10.7416/ai.2019.2321. Guh, D. P., W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis. 2009. “The

Incidence of Co-Morbidities Related to Obesity and Overweight: A Systematic Review and

Meta-Analysis.” BMC Public Health 9: 88. doi:10.1186/1471-2458-9-88. IHME (Institute for Health Metrics and Evaluation). 2019. Global Burden of Disease database.

Seattle: University of Washington. http://www.healthdata.org/gbd/2019. Keaver, L., L. Webber, A. Dee, F. Shiely, T. Marsh, K. Balanda, and I. Perry. 2013. “Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of

Projected Obesity Trends in Ireland.” PLoS One 8 (12). doi:10.1371/journal.pone.0079827. MOH (Ministry of Health). 2020. Kingdom of Saudi Arabia World Health Survey 2019 Report.

Riyadh: Ministry of Health. MOH and IHME (Ministry of Health and Institute for Health Metrics and Evaluation). 2013.

Saudi Health Interview Survey Results. Seattle: University of Washington. http://www .healthdata.org/sites/default/files/files/Projects/KSA/Saudi-Health-Interview-Survey -Results.pdf. OECD Public Health Explorer. 2019. SPHeP-NCDs Documentation, Modelling the Burden of

Disease. Paris: Organisation for Economic Co-operation and Development. http:// oecdpublichealthexplorer.org/ncd-doc/_2_1_Modelling_Principles.html#. Souliotis, K., H. Kousoulakou, G. Hillas, N. Tzanakis, M. Toumbis, and T. vassilakopoulos. 2017.

“The Direct and Indirect Costs of Managing Chronic Obstructive Pulmonary Disease in

Greece.” International Journal of Chronic Obstructive Pulmonary Disease 12: 1395–400. https://pubmed.ncbi.nlm.nih.gov/28546747/. Tonorezos, E. S., A. M. Karpati, Y. Wang, and R. G. Barr. 2008. “Does the Relationship between

Asthma and Obesity Differ by Neighborhood?” Respiratory Medicine 102 (12): 1797–804. doi:10.1016/j.rmed.2008.06.018. UN Interagency Task Force on NCDs (United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases). 2018. The Investment Case for Noncommunicable

Disease Prevention and Control in the Kingdom of Saudi Arabia: Return on Investment

Analysis and Institutional and Context Analysis, August 2017. Geneva: World Health

Organization. https://www.undp.org/content/dam/saudi_arabia/docs/Publications /180326%20MOH%20KSA%20NCDs%202017.pdf. US EPA (United States Environmental Protection Agency). 2020. Mortality Risk Valuation.

Updated November 20. Washington, DC: US EPA. https://www.epa.gov/environmental -economics/mortality-risk-valuation#means. viscusi, W. K., and C. J. Masterman. 2017. “Income Elasticities and Global values of a Statistical

Life.” Journal of Benefit-Cost Analysis 8 (2): 226–50. doi:10.1017/bca.2017.12. Wacker, M. E., R. A. Jörres, H. Schulz, J. Heinrich, S. Karrasch, A. Karch, A. Koch, A. Peters,

R. Leidl, C. vogelmeier, R. Holle, and the COCSYNCONET-Consortium. 2016. “Direct and

Indirect Costs of COPD and Its Comorbidities: Results from the German COSYCONET

Study.” Respiratory Medicine 111: 39–46. https://pubmed.ncbi.nlm.nih.gov/26725462/.

WHO (World Health Organization). n.d. Cost Effectiveness and Strategic Planning (WHO-

CHOICE). OneHealth Tool. Geneva: WHO. https://www.who.int/choice/onehealthtool /en/. World Bank. 2018a. GDP, PPP (Current International $)—Saudi Arabia. World Bank data, accessed May 20, 2020. https://data.worldbank.org/indicator/NY.GDP.PCAP.PP .KD?locations=SA.

World Bank. 2018b. Population, Total—Saudi Arabia. World Bank data, accessed May 20, 2020. https://data.worldbank.org/indicator/SP.POP.TOTL?locations=SA&display=graph. World Bank. n.d. World Bank Open Data, accessed May 20, 2020. https://data.worldbank.org/.